Annual ROE
-139.14%
+174.84%+55.69%
31 December 2023
Summary:
Titan Pharmaceuticals annual return on equity is currently -139.14%, with the most recent change of +174.84% (+55.69%) on 31 December 2023. During the last 3 years, it has risen by +63.31% (+31.27%). TTNP annual ROE is now -168.98% below its all-time high of 201.72%, reached on 31 December 1995.TTNP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-87.88%
+12.06%+12.07%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly return on equity is currently -87.88%, with the most recent change of +12.06% (+12.07%) on 30 June 2024. Over the past year, it has increased by +78.00% (+47.02%). TTNP quarterly ROE is now -113.30% below its all-time high of 660.61%, reached on 31 December 2013.TTNP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +47.0% |
| 3 y3 years | +31.3% | +30.1% |
| 5 y5 years | +65.1% | +91.4% |
TTNP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.7% | at high | +80.8% |
| 5 y | 5 years | at high | +81.1% | at high | +95.7% |
| alltime | all time | -169.0% | +81.1% | -113.3% | +97.8% |
Titan Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -87.88%(-12.1%) |
| Mar 2024 | - | -99.94%(-39.8%) |
| Dec 2023 | -139.14%(-55.7%) | -165.88%(-45.2%) |
| Sept 2023 | - | -302.58%(-34.0%) |
| June 2023 | - | -458.36%(+78.1%) |
| Mar 2023 | - | -257.33%(+19.0%) |
| Dec 2022 | -313.98%(+55.1%) | -216.23%(+26.3%) |
| Sept 2022 | - | -171.19%(+26.5%) |
| June 2022 | - | -135.37%(+22.5%) |
| Mar 2022 | - | -110.53%(-12.1%) |
| Dec 2021 | -202.45%(-72.4%) | -125.76%(-22.1%) |
| Sept 2021 | - | -161.50%(-40.0%) |
| June 2021 | - | -269.13%(-31.6%) |
| Mar 2021 | - | -393.27%(-53.0%) |
| Dec 2020 | -734.82%(+84.5%) | -836.48%(-58.7%) |
| Sept 2020 | - | -2026.53%(+20.3%) |
| June 2020 | - | -1684.10%(+25.6%) |
| Mar 2020 | - | -1341.27%(+31.8%) |
| Dec 2019 | -398.31%(+69.7%) | -1017.43%(+54.2%) |
| Sept 2019 | - | -659.63%(+16.6%) |
| June 2019 | - | -565.67%(+36.7%) |
| Mar 2019 | - | -413.70%(+1.0%) |
| Dec 2018 | -234.73%(+15.2%) | -409.47%(-26.6%) |
| Sept 2018 | - | -557.99%(+1.2%) |
| June 2018 | - | -551.15%(+75.9%) |
| Mar 2018 | - | -313.31%(+58.7%) |
| Dec 2017 | -203.69%(-500.3%) | -197.44%(+54.1%) |
| Sept 2017 | - | -128.11%(+44.4%) |
| June 2017 | - | -88.70%(-377.6%) |
| Mar 2017 | - | 31.95%(-27.1%) |
| Dec 2016 | 50.89%(-135.2%) | 43.81%(-7.9%) |
| Sept 2016 | - | 47.57%(-34.7%) |
| June 2016 | - | 72.85%(-148.8%) |
| Mar 2016 | - | -149.27%(-18.8%) |
| Dec 2015 | -144.59%(+332.4%) | -183.73%(+8.6%) |
| Sept 2015 | - | -169.16%(+9.8%) |
| June 2015 | - | -154.10%(+39.1%) |
| Mar 2015 | - | -110.82%(+143.2%) |
| Dec 2014 | -33.44%(-119.8%) | -45.57%(-20.0%) |
| Sept 2014 | - | -56.95%(-52.5%) |
| June 2014 | - | -119.95%(-227.9%) |
| Mar 2014 | - | 93.78%(-85.8%) |
| Dec 2013 | 168.59%(+156.9%) | 660.61%(-494.1%) |
| Sept 2013 | - | -167.61%(+673.1%) |
| June 2013 | - | -21.68%(-203.0%) |
| Mar 2013 | - | 21.05%(-66.4%) |
| Dec 2012 | 65.63%(-13.3%) | 62.63%(-17.4%) |
| Sept 2012 | - | 75.82%(+50.9%) |
| June 2012 | - | 50.24%(-38.0%) |
| Mar 2012 | - | 80.99%(-13.4%) |
| Dec 2011 | 75.72%(-32.9%) | 93.50%(-28.2%) |
| Sept 2011 | - | 130.19%(-25.9%) |
| June 2011 | - | 175.64%(-7.5%) |
| Mar 2011 | - | 189.87%(+0.4%) |
| Dec 2010 | 112.90% | 189.18%(-138.4%) |
| Sept 2010 | - | -492.98%(+290.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | -126.28%(+118.5%) |
| Mar 2010 | - | -57.80%(+39.6%) |
| Dec 2009 | -44.62%(-51.7%) | -41.40%(-63.5%) |
| June 2009 | - | -113.31%(-19.4%) |
| Mar 2009 | - | -140.52%(-8.8%) |
| Sept 2008 | - | -154.12%(+14.9%) |
| June 2008 | - | -134.10%(+12.9%) |
| Mar 2008 | - | -118.76%(-0.9%) |
| Dec 2007 | -92.31%(-17.2%) | -119.79%(+0.5%) |
| Sept 2007 | - | -119.14%(+11.5%) |
| June 2007 | - | -106.82%(+10.3%) |
| Mar 2007 | - | -96.87%(+2.8%) |
| Dec 2006 | -111.42%(+27.9%) | -94.24%(+1.1%) |
| Sept 2006 | - | -93.26%(-2.5%) |
| June 2006 | - | -95.63%(-1.9%) |
| Mar 2006 | - | -97.53%(+4.2%) |
| Dec 2005 | -87.14%(+35.1%) | -93.58%(+4.0%) |
| Sept 2005 | - | -89.98%(+22.2%) |
| June 2005 | - | -73.64%(+18.3%) |
| Mar 2005 | - | -62.26%(+7.8%) |
| Dec 2004 | -64.51%(+27.0%) | -57.75%(-2.4%) |
| Sept 2004 | - | -59.15%(+7.2%) |
| June 2004 | - | -55.20%(+2.5%) |
| Mar 2004 | - | -53.83%(+6.0%) |
| Dec 2003 | -50.81%(+56.3%) | -50.78%(+18.2%) |
| Sept 2003 | - | -42.95%(+6.6%) |
| June 2003 | - | -40.30%(+8.7%) |
| Mar 2003 | - | -37.06%(+15.1%) |
| Dec 2002 | -32.51%(+102.3%) | -32.21%(+19.2%) |
| Sept 2002 | - | -27.03%(+18.1%) |
| June 2002 | - | -22.89%(+35.4%) |
| Mar 2002 | - | -16.90%(+6.5%) |
| Dec 2001 | -16.07%(-30.9%) | -15.87%(+10.3%) |
| Sept 2001 | - | -14.39%(-24.5%) |
| June 2001 | - | -19.06%(-8.4%) |
| Mar 2001 | - | -20.81%(-10.3%) |
| Dec 2000 | -23.27%(-42.2%) | -23.21%(-22.0%) |
| Sept 2000 | - | -29.75%(+20.5%) |
| June 2000 | - | -24.69%(-33.6%) |
| Mar 2000 | - | -37.16%(-40.9%) |
| Dec 1999 | -40.29%(-44.9%) | -62.85%(-37.3%) |
| Sept 1999 | - | -100.17%(+10.1%) |
| June 1999 | - | -90.98%(+21.3%) |
| Mar 1999 | - | -75.03%(+10.3%) |
| Dec 1998 | -73.10%(-1988.9%) | -68.04%(-252.6%) |
| Sept 1998 | - | 44.58%(+2.2%) |
| June 1998 | - | 43.63%(-69.2%) |
| Mar 1998 | - | 141.44%(+1516.5%) |
| Dec 1997 | 3.87%(-101.2%) | 8.75%(-103.4%) |
| Sept 1997 | - | -260.87%(+23.5%) |
| June 1997 | - | -211.23%(-23.3%) |
| Mar 1997 | - | -275.49%(+58.5%) |
| Dec 1996 | -322.50%(-259.9%) | -173.85%(-10.5%) |
| Sept 1996 | - | -194.29%(-55.7%) |
| June 1996 | - | -439.02%(-89.2%) |
| Mar 1996 | - | -4066.67%(-2116.0%) |
| Dec 1995 | 201.72% | 201.72% |
FAQ
- What is Titan Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly ROE year-on-year change?
What is Titan Pharmaceuticals annual return on equity?
The current annual ROE of TTNP is -139.14%
What is the all time high annual ROE for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual return on equity is 201.72%
What is Titan Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TTNP is -87.88%
What is the all time high quarterly ROE for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly return on equity is 660.61%
What is Titan Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TTNP quarterly return on equity has changed by +78.00% (+47.02%)